InhaleRx Limited's market cap is currently AU$4.91M. The company's EPS TTM is AU$-0.004; its P/E ratio is ―; InhaleRx Limited is scheduled to report earnings on February 24, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	AU$ 1.20M	AU$ 24.80K	AU$ 167.30K	AU$ 97.50K	AU$ 46.60K
Gross Profit	AU$ 1.20M	AU$ 15.09K	AU$ 52.07K	AU$ -26.43K	AU$ -576.05K
Operating Income	AU$ -1.39M	AU$ -1.92M	AU$ -1.13M	AU$ -1.02M	AU$ -1.64M
EBITDA	AU$ -1.41M	AU$ -1.94M	AU$ -1.12M	AU$ -1.22M	AU$ -1.84M
Net Income	AU$ -1.44M	AU$ -1.90M	AU$ -1.11M	AU$ -1.01M	AU$ -2.27M
Balance Sheet
Cash & Short-Term Investments	AU$ 715.82K	AU$ 2.13M	AU$ 2.80M	AU$ 1.72M	AU$ 424.96K
Total Assets	AU$ 1.58M	AU$ 2.26M	AU$ 2.93M	AU$ 1.90M	AU$ 623.71K
Total Debt	AU$ 560.27K	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -155.54K	AU$ -2.13M	AU$ -2.80M	AU$ -1.72M	AU$ -424.96K
Total Liabilities	AU$ 911.41K	AU$ 355.32K	AU$ 253.34K	AU$ 580.10K	AU$ 283.63K
Stockholders' Equity	AU$ 665.47K	AU$ 1.90M	AU$ 2.68M	AU$ 1.32M	AU$ 340.08K
Cash Flow
Free Cash Flow	AU$ -1.96M	AU$ -1.85M	AU$ -1.19M	AU$ -1.09M	AU$ -1.90M
Operating Cash Flow	AU$ -1.96M	AU$ -1.85M	AU$ -1.16M	AU$ -1.09M	AU$ -1.87M
Investing Cash Flow	AU$ 0.00	AU$ -175.00	AU$ -25.09K	AU$ -4.30K	AU$ -36.34K
Financing Cash Flow	AU$ 544.29K	AU$ 1.18M	AU$ 2.26M	AU$ 2.37M	AU$ 6.60K

Currency in AUD

InhaleRx Limited Earnings and Revenue History

Income Statement >

InhaleRx Limited Debt to Assets

Balance Sheet >

InhaleRx Limited Cash Flow

Cash Flow >

InhaleRx Limited Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing